Human Vaccines Market

Human Vaccines Market - Global Industry
Analysis, Size, Share, Growth, Trends and
Forecast 2016 - 2024
Owing to the presence of a few, but extremely large players
operating in the market, the competitive rivalry among the
players is intense, states Transparency Market Research (TMR)
in a research report. The global market for human vaccine is
characterized by extensive efforts on research and development
and technological advancements. Various strategies are being
implemented by manufacturers in this industry in order to gain
and withstand competitive benefit.
The players in this market strive to bring about product
differentiation and expand customer base through mergers and
acquisitions. The global human vaccine market is ruled by
leading global players such as GlaxoSmithKline plc., Sanofi SA,
Pfizer, Inc., and Merck & Co. Inc. These players jointly
accounted for over 70% of the market in terms of revenue in
2015. Pfizer led this list closely trailed by Merck & Co. Inc.,
Sanofi SA, and GlaxoSmithKline plc. in the exact order.
According to a TMR researcher, “The global market for human
vaccine was worth US$28.3 bn in 2015 and is projected to rise
to a valuation of US$72.5 bn by the end of 2024. It is expected
to register a CAGR of 11.2% between 2016 and 2024.”

Conjugate Vaccines to Gain Prominence over Time
The conjugate vaccines segment held the leading share of 38%
in the global human vaccines market in 2015. This is due to
presence of blockbuster drug Prevnar under this category. High
product revenue of Prevnar and snowballing preference for
vaccination among children is expected to boost the demand for
this vaccine in the coming years.
Browse Full Research Report on Human Vaccines Market:
http://www.transparencymarketresearch.com/human-vaccinesmarket.html
Conjugate vaccines are made of polysaccharides or
oligosaccharides antigens amalgamating with a protein carrier.
Protein, along with the saccharide chain provokes strong
resistant response in children. Conjugate vaccines are mostly
employed for the following vaccination: pneumococcal,
meningococcal, flu, and others. Prevnar and Menactra are the
noticeable brands in this segment.
Region-wise, North America surfaced as the most attractive
region for the human vaccine market to grow. The prime driver
of this market in North America is the outbreak of diseases in
the region.

The human vaccine market in the U.S. is growing exponentially
owing to rising awareness among consumers regarding the
important of vaccination and less side effects related to it. At
present, Europe is the second most lucrative market with leading
players investing vigorously in expanding the market in this
region. Asia Pacific is expected to emerge as the leading region
in terms of growth in the global human vaccine market over the
forecast period.
Fatal Side Effects and Low Risk Factor to Bode Well for
Market
Like other drugs, vaccines are also connected to certain side
effects. However, maximum of the times, side effects related to
vaccination are mild and moderate such as soreness, swelling, or
redness at the site of injection and fever, rash, and achiness. The
risk of serious and fatal side effects with vaccination is
extremely low. For instance, stern allergic reaction with Anthrax
vaccine is less than once for every 100,000 doses.
A number of health care organizations including the CDC, the
FDA, the American Medical Association (AMA), and the
American Academy of Pediatrics (AAP) also recommend that

vaccines are safe. Tremendously low risk of serious and deadly
side effects associated with vaccines is anticipated to drive the
market for vaccines during the forecast period. However,
stringent regulatory pathway and high cost in association with
new vaccine are likely to hamper the growth of the market in the
coming years.
This review of the market is based on a recent market research
report published by Transparency Market Research, titled,
“Human Vaccines Market (Vaccine Type - Conjugate,
Recombinant, Inactivated, Combination, and Attenuated;
Product - Pneumococcal, Influenza, Hepatitis, HPV,
Meningococcal, Rotavirus, Measles, Typhoid, and Combination;
Age Group - Pediatrics, Adolescents, Adults, and Geriatrics;
Distribution Channel - Hospital Pharmacies and Drugstores) -
Global Industry Analysis, Size, Share, Growth, Trends, and
Forecast 2016 - 2024.”
Browse Full Press Release on Human Vaccines Market:
Press Release
About Us
Transparency Market Research (TMR) is a global market
intelligence company providing business information reports
and services. The company’s exclusive blend of quantitative

forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze
information.
TMR’s data repository is continuously updated and revised by a
team of research experts so that it always reflects the latest
trends and information. With extensive research and analysis
capabilities, Transparency Market Research employs rigorous
primary and secondary research techniques to develop
distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com